Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by LithLoveron Aug 19, 2022 11:59am
150 Views
Post# 34907544

RE:Brady

RE:BradyIf you are trying to hint at Tripp not having an incentive or skin in the game you are incorrect. 

In addition to his shares there are stock options of nearly 5 million

All issued and outstanding stock options at June 30, 2022 of 4,833,649


 And re-read the new from yesterday:  all with a view to minimizing dilution for the Company's shareholders," commented James Howard-Tripp, Chairman and CEO of StageZero Life Sciences.


4real4ever wrote:

Insider Roster

Individual or Entity Most Recent Transaction Date Shares Owned as of Transaction Date
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

HEALTH CLINICS LIMITED
10% Security Holder of Issuer

Opening Balance-Initial SEDI Report

Sep 01, 2021

12,400,000

HOWARD-TRIPP (JAMES)
Director of Issuer

Acquisition or disposition in the public market

Aug 18, 2021

261,059




<< Previous
Bullboard Posts
Next >>